Where Glaukos Stands With Analysts
Within the last quarter, Glaukos (NYSE:GKOS) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.
Stifel Maintains Buy Rating for Glaukos: Here’s What You Need To Know
Stifel has decided to maintain its Buy rating of Glaukos (NYSE:GKOS) and raise its price target from $65.00…
8 Analysts Have This to Say About Glaukos
Within the last quarter, Glaukos (NYSE:GKOS) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Glaukos Poised for $1B in Sales by 2030: Piper Sandler Predicts With Stock Upgrade
Piper Sandler has upgraded Glaukos Corporation (NYSE: GKOS) to Overweight from a Neutral ra
Benzinga’s Top Ratings Upgrades, Downgrades For June 7, 2023
Upgrades According to Janney Montgomery Scott, the prior rating for Consolidated Water Co Ltd (NASDAQ:CWCO) was changed from…
Analyst Expectations for Glaukos’s Future
Within the last quarter, Glaukos (NYSE:GKOS) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Tyson Foods, PayPal And 3 Stocks To Watch Heading Into Monday
With US stock futures trading slightly lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Glaukos Announces FDA Acceptance Of NDA Submission For iDose TR
PDUFA Date Set for December 22, 2023
Glaukos Corporation (NYSE:GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal
Glaukos: Q1 Earnings Insights
Glaukos (NYSE:GKOS) reported its Q1 earnings results on Wednesday, May 3, 2023 at 04:05 PM. Here’s what investors…